Table of Contents
List of Tables
List of Figures
1 Introduction
1.1 What Is This Report About?
1.2 Aortic Stent Grafts Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Aortic Stent Grafts Market, EU5
2.1 Aortic Stent Grafts Market, EU5, Revenue ($m), 2024-2036
2.2 Aortic Stent Grafts Market, EU5, Revenue ($m), 2024-2036
2.3 Aortic Stent Grafts Market, EU5, Volume (Units), 2024-2036
2.4 Aortic Stent Grafts Market, EU5, Volume (Units), 2024-2036
2.5 Aortic Stent Grafts Market, EU5, Company Share by Revenue ($m), 2025
3 Aortic Stent Grafts Market, France
3.1 Aortic Stent Grafts Market, France, Revenue ($m), 2024-2036
3.1.1 Extension Pieces Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Aortic Stent Grafts Market, France, Volume (Units), 2024-2036
3.2.1 Extension Pieces Market, France, Volume (Units), by Segment, 2024-2036
3.3 Aortic Stent Grafts Market, France, Average Price ($), 2024-2036
3.4 Aortic Stent Grafts Market, France, Company Share by Revenue ($m), 2025
4 Aortic Stent Grafts Market, Germany
4.1 Aortic Stent Grafts Market, Germany, Revenue ($m), 2024-2036
4.1.1 Extension Pieces Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Aortic Stent Grafts Market, Germany, Volume (Units), 2024-2036
4.2.1 Extension Pieces Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Aortic Stent Grafts Market, Germany, Average Price ($), 2024-2036
4.4 Aortic Stent Grafts Market, Germany, Company Share by Revenue ($m), 2025
5 Aortic Stent Grafts Market, Italy
5.1 Aortic Stent Grafts Market, Italy, Revenue ($m), 2024-2036
5.1.1 Extension Pieces Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Aortic Stent Grafts Market, Italy, Volume (Units), 2024-2036
5.2.1 Extension Pieces Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Aortic Stent Grafts Market, Italy, Average Price ($), 2024-2036
5.4 Aortic Stent Grafts Market, Italy, Company Share by Revenue ($m), 2025
6 Aortic Stent Grafts Market, Spain
6.1 Aortic Stent Grafts Market, Spain, Revenue ($m), 2024-2036
6.1.1 Extension Pieces Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Aortic Stent Grafts Market, Spain, Volume (Units), 2024-2036
6.2.1 Extension Pieces Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Aortic Stent Grafts Market, Spain, Average Price ($), 2024-2036
6.4 Aortic Stent Grafts Market, Spain, Company Share by Revenue ($m), 2025
7 Aortic Stent Grafts Market, United Kingdom
7.1 Aortic Stent Grafts Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Extension Pieces Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Aortic Stent Grafts Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Extension Pieces Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Aortic Stent Grafts Market, United Kingdom, Average Price ($), 2024-2036
7.4 Aortic Stent Grafts Market, United Kingdom, Company Share by Revenue ($m), 2025
8 Aortic Stent Grafts Market Pipeline Products
8.1 Aortic Stent Grafts Market Pipeline Products
8.2 Aortic Stent Grafts – Pipeline Products by Stage of Development
8.3 Aortic Stent Grafts – Pipeline Products by Segment
8.4 Aortic Stent Grafts – Pipeline Products by Territory
8.5 Aortic Stent Grafts – Pipeline Products by Regulatory Path
8.6 Aortic Stent Grafts – Pipeline Products by Estimated Approval Date
9 Overview of Key Companies in Europe Aortic Stent Grafts Market
9.1 W. L. Gore & Associates Inc
9.1.1 Company Overview
9.2 Cook Medical LLC
9.2.1 Company Overview
9.3 Medtronic Plc
9.3.1 Company Overview
9.4 Endologix LLC
9.4.1 Company Overview
9.5 Terumo Corp
9.5.1 Company Overview
10 Recent Developments
10.1 Corporate Communications
10.1.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.2 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors
10.1.3 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
10.1.4 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
10.2 Financial Announcements
10.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
10.2.2 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025
10.3 Government and Public Interest
10.3.1 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences
10.3.2 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference
10.4 Other Significant Developments
10.4.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.4.2 Oct 17, 2025: New Value Based Procurement Guidelines Launched
10.4.3 Oct 16, 2025: Shape Memory Medical Reaches Midway Milestone in AAA-SHAPE Trial
10.5 Product News
10.5.1 Nov 19, 2025: BeGraft Plus CE-Approved for Use as BEVAR Bridging Stent
10.5.2 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
10.5.3 Nov 05, 2025: Fluid Control Solutions For MedTech
10.5.4 Oct 16, 2025: Shape Memory Medical Reaches Midway Milestone in AAA-SHAPE Trial
10.5.5 Oct 13, 2025: Getinge’s Advanta V12 Receives CE Mark for Major Bridging Indications
10.5.6 Oct 01, 2025: Bentley and Terumo Aortic Collaborate on Clinical Study for FEVAR Procedures
10.6 Strategy And Business Planning
10.6.1 Apr 01, 2026: Tempus and Medtronic Announce Alert Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease
10.6.2 Nov 20, 2025: New Propelus Prototype Centers
10.6.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.6.4 Oct 01, 2025: Bentley and Terumo Aortic Collaborate on Clinical Study for FEVAR Procedures
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 GlobalData Consulting
11.3 Contact Us
11.4 Disclaimer